| Literature DB >> 19089257 |
Ana Carolina Valinoti1, Beatriz Gonçalves Neves, Eduardo Moreira da Silva, Lucianne Cople Maia.
Abstract
This study evaluated the effects of acidic medicines (Dimetapp and Claritin), under pH-cycling conditions, on the surface degradation of four composite resins (microhybrid: TPH, Concept, Opallis and Nanofilled: Supreme). Thirty disc-shaped specimens ([symbol: see text] = 5.0 mm/thickness = 2.0 mm) of each composite were randomly assigned to 3 groups (n = 10): a control and two experimental groups, according to the acidic medicines evaluated. The specimens were finished and polished with aluminum oxide discs, and the surface roughness was measured by using a profilometer. After the specimens were submitted to a pH-cycling regimen and immersion in acidic medicines for 12 days, the surface roughness was measured again. Two specimens for each material and group were analyzed by scanning electron microscopy (SEM) before and after pH-cycling. Data were analyzed by the Student's-t test, ANOVA, Duncan's multiple range test and paired t-test (alpha=0.05). Significant increase in roughness was found only for TPH in the control group and TPH and Supreme immersed in Claritin (p<0.05). SEM analyses showed that the 4 composite resins underwent erosion and surface degradation after being subjected to the experimental conditions. In conclusion, although the roughness was slightly affected, the pH-cycling and acidic medicines caused surface degradation of the composite resins evaluated. Titratable acidity seemed to play a more crucial role on surface degradation of composite resins than pH.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19089257 PMCID: PMC4327534 DOI: 10.1590/s1678-77572008000400006
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Composition and specifications of composite resins used in this study
| Composite resins | Composition | Manufacturer |
|---|---|---|
| TPH 3 | Polymer matrix: Bis-GMA, Bis-EMA and TEGDMA | Denstply Ind. e Com. Ltda., Petrópolis, RJ, Brazil |
| Concept Advanced Magic Kids© | Polymer matrix: Bis-GMA, UDMA and Esther of methacrylic acid | Vigodent, Rio de Janeiro, RJ, Brazil |
| Opallis | Polymer matrix: BisGMA, BisEMA, and TEGDMA | FGM, Joinville, SC, Brazil |
| Supreme | Polymer matrix: Bis-GMA, Bis-EMA, UDMA TEGDMA | 3M/ESPE, St. Paul, MN, USA |
*Bis-GMA= 2,2-bis[4-(2′-hydroxy-3′methacryloxypropoxy)phenyl]propane; TEGDMA= triethylene glycol dimethacrylate); UDMA=1,6-bis(methacryloxy-2-ethoxycarbonylamino)-2,4,4-trimethylhexane; Bis-EMA=ethoxylated bisphenol A glycol, dimethacrylate.
Characteristics of the acidic medicines used in the present study
| Characteristics | Medicines | |
|---|---|---|
| Claritin® (E1) | Dimetapp Elixir® (E2) | |
| Batch Number | 701 | 46139A |
| Active Principle | Loratadine | Brompheniramine and Pseudoephedrine |
| pH | 2.57 | 2.51 |
| Titratable acidity mean volume of 0.05 N NaOH (mL) | 41.83 mL | 36.31 mL |
| Viscosity at 20s-1 | 19.7 | 13.3 |
| Acid content according to manufacturers (mg/mL) | Citric Acid (8.8 mg/mL) | Citric Acid (7.5 mg/mL) |
FIGURE 1Schematic design of the pH-cycling and medicine immersion
FIGURE 2Surface roughness before pH-cycling. Columns with the same letters do not differ significantly (α = 0.05)
Results of paired t-test for surface roughness means (Ra; mm) before and after pH-cycling
| Before pH-cycling | After pH-cycling | P | Roughness variation | |
|---|---|---|---|---|
| TPH E1 | 0.089 (0.012) | 0.101 (0.012) | 0.030 | 0.0129 |
| TPH E2 | 0.112 (0.020) | 0.114 (0.020) | 0.804 | 0.0023 |
| TPH Control | 0.096 (0.001) | 0.117 (0.015) | 0.003 | 0.0213 |
| Concept E1 | 0.116 (0.032) | 0.124 (0.026) | 0.554 | 0.008 |
| Concept E2 | 0.119 (0.019) | 0.130 (0.009) | 0.109 | 0.0114 |
| Concept Control | 0.121 (0.025) | 0.115 (0.018) | 0.589 | -0.0054 |
| Opallis E1 | 0.145 (0.083) | 0.128 (0.023) | 0.537 | -0.0173 |
| Opallis E2 | 0.110 (0.015) | 0.110 (0.015) | 0.932 | -0.0006 |
| Opallis Control | 0.111 90.016) | 0.106 (0.019) | 0.518 | -0.0054 |
| Supreme E1 | 0.091 (0.021) | 0.117 (0.024) | 0.025 | 0.0253 |
| Supreme E2 | 0.118 (0.061) | 0.105 (0.024) | 0.554 | -0.0126 |
| Supreme Control | 0.101 (0.024) | 0.101 (0.027) | 0.985 | -0.0002 |
Significant at α= 0.05
FIGURE 3Representative SEM micrographs of resin-based composites before pH-cycling. (a) TPH, (b) Concept, (c) Opallis and (d) Supreme
FIGURE 4Representative SEM photomicrographs of resin-based composites after pH-cycling and immersion in distilled water, control group. (a) TPH, (b) Concept, (c) Opallis and (d) Supreme
FIGURE 5Representative SEM photomicrographs of resin-based composites after pH-cycling and immersion in Claritin®. (a) TPH, (b) Concept, (c) Opallis and (d) Supreme
FIGURE 6Representative SEM photomicrographs of resin-based composites after pH-cycling and immersion in Dimetapp®. (a) TPH, (b) Concept, (c) Opallis and (d) Supreme